- Rekrutierung läuftAn Open-Label, Phase 2 Trial of Nanatinostat in Combination with Valganciclovirin Patients with Epstein-Barr Virus-Positive (EBV+) Relapsed/Refractory Lymphomas(NAVAL-1)
- Rekrutierung läuft
Efficacy and safety investigation of NNC0194-0499 co-administered with semaglutide in subjects with non-alcoholic steatohepatitis: a dose-ranging, placebo-controlled trial
- Rekrutierung läuftGanzhirnbestrahlung mit Hippocampusschonung und Dosiseskalation auf die Metastasen: neurokognitive Untersuchungen und biologische Bildgebung
- Rekrutierung läuft
A Phase 2, Open-Label, Parallel Cohort Study of Subcutaneous Amivantamab in Multiple Regimens in Patients with Advanced or Metastatic Solid Tumors including EGFR-mutated Non-Small Cell Lung Cancer [CR109264]
Molekulare Marker - Rekrutierung läuftMRD-guided treatment with pembrolizumab and azacitidine in NPM1mut AML patients with an imminent hematological relapse TUD-PEMAZA-068IndikationenMolekulare Marker
- Rekrutierung läuftA Phase 2, single arm study on dacarbazine (DTIC) followed by immunotherapy re-challenge in unresectable or metastatic melanoma with primary resistance to PD-1/PD-L1 or PD-1 + CTLA4 BlockadeIndikationen
- Rekrutierung läuftEfficacy Comparison of Dostarlimab Plus Chemotherapy vs Pembrolizumab plus Chemotherapy in Participants with metatstatic non-squamous non-small Cell Lung
- Rekrutierung läuft
An Open-Label Study to Assess the Anti-Tumor Activity and Safety of REGN1979, an Anti CD20 x Anti-CD3 Bispecific Antibody, in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphom
Molekulare Marker - Rekrutierung läuft
Radiochemotherapie +/- Durvalumab zur Behandlung des lokal fortgeschrittenen Analkarzinoms. Eine multizentrische, randomisierte Phase II-Studie der German Anal Cancer Study Group
Molekulare Marker - Rekrutierung läuft
A Phase 1/2, First-in-Human, Open-Label, Dose Escalation Study of Talquetamab, a
Humanized GPRC5D x CD3 Bispecific Antibody, in Subjects with Relapsed or Refractory
Multiple Myeloma.Phase 2 (Part 3)
Molekulare Marker